Amedeo Smart

Free Medical Literature Service



Ovarian Neoplasms

  Free Subscription

Articles published in
Anticancer Drugs
    August 2022
  1. SHAN Y, Zhang B, Chen L, Zhang H, et al
    Herpesvirus entry mediator regulates the transduction of Tregs via STAT5/Foxp3 signaling pathway in ovarian cancer cells.
    Anticancer Drugs. 2022 Aug 9. pii: 00001813-990000000-00021.
    >> Share

  2. ZHANG X, Hong S, Yang J, Liu J, et al
    Purvalanol A induces apoptosis and reverses cisplatin resistance in ovarian cancer.
    Anticancer Drugs. 2022 Aug 9. pii: 00001813-990000000-00018.
    >> Share

    March 2022
  3. MICHA J, Rettenmaier M, Giuliano P, Bohart R, et al
    Oncolytic viral therapy engenders a clinical response in a recurrent ovarian cancer patient.
    Anticancer Drugs. 2022 Mar 23. pii: 00001813-900000000-98204.
    >> Share

  4. FANG W, Xia Y
    LncRNA HLA-F-AS1 attenuates the ovarian cancer development by targeting miR-21-3p/PEG3 axis.
    Anticancer Drugs. 2022 Mar 8. pii: 00001813-900000000-98225.
    >> Share

    September 2021
  5. ROSE PG, Yao M, Chambers LM, Mahdi H, et al
    PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer.
    Anticancer Drugs. 2021 Sep 13. pii: 00001813-900000000-98269.
    >> Share

    August 2021
  6. PARK GB, Jeong JY, Choi S, Yoon YS, et al
    Glucose deprivation enhances resistance to paclitaxel via ELAVL2/4-mediated modification of glycolysis in ovarian cancer cells.
    Anticancer Drugs. 2021 Aug 19. pii: 00001813-900000000-98297.
    >> Share

    July 2021
  7. SUN S, Sun W, Xiang Q, Yang C, et al
    Persistent response of an ovarian cancer patient after a short-term single-agent immunotherapy: a case report.
    Anticancer Drugs. 2021 Jul 30. pii: 00001813-900000000-98352.
    >> Share

    March 2021
  8. WEI S, Qi L, Wang L
    Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
    Anticancer Drugs. 2021 Mar 16. pii: 00001813-900000000-98432.
    >> Share

    January 2021
  9. ZHANG W, Huang X, Shi J
    EZH2-mediated lncRNA ABHD11-AS1 promoter regulates the progression of ovarian cancer by targeting miR-133a-3p.
    Anticancer Drugs. 2021 Jan 22. pii: 00001813-900000000-98466.
    >> Share

    June 2020
  10. HU H, Zhu S, Tong Y, Huang G, et al
    Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro.
    Anticancer Drugs. 2020;31:483-491.
    >> Share

    November 2019
  11. GUO Q, Yang Q, Li J, Liu G, et al
    Targeted therapy clinical trials in ovarian cancer: improved outcomes by gene mutation screening.
    Anticancer Drugs. 2019 Nov 15. doi: 10.1097/CAD.0000000000000858.
    >> Share

    September 2019
  12. MORI KM, Giuliano PD, Lopez KL, King MM, et al
    Pronounced clinical response following the oncolytic vaccinia virus GL-ONC1 and chemotherapy in a heavily pretreated ovarian cancer patient.
    Anticancer Drugs. 2019 Sep 16. doi: 10.1097/CAD.0000000000000836.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016